|
RNCOS Releases a New Report- Japanese Generic Market Forecast to 2013
According to "Japanese Generic Market Forecast to 2013", a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue.
The Japanese market is characterized by a strong support by the government,
which in a desperate bid to limit its healthcare costs, is introducing a
number of generic-friendly policies. Other factors such as a large number of
patent expiries and the largely un-penetrated nature of the market are also
contributing towards the market growth.
The generic market is presently dominated by domestic manufacturers, with
the top six manufacturers accounting for 56% of the total market in 2007.
But opening up of the market and introduction of a number of
generic-friendly reforms is attracting a number of foreign players in the
market.
Despite such a big opportunity for future, the market also has a number
challenges to deal with. Generic drugs are still regarded as cheap, low
quality alternatives of branded drugs. Thus, both physicians and patients
are skeptic regarding their safety and efficacy. A number of awareness and
educational programs, however, are expected to increase their awareness in
future.
Despite these challenges, our forecast models suggest that the generic drugs
market will grow at a CAGR of around 8.8% between 2009 and 2013.
The report gives an extensive and objective analysis on the generic market
in Japan. It investigates both the past and present trends in the generic
market, but its focus is on the future trends shaping the industry. The
report also i nvestigates the performance of various players in the Japanese
pharmaceutical and generic markets, and analyzes the competitive landscape
in these markets. Based on various present and future indicators, the future
scenario of the market has also been analyzed.
Key questions answered in the report
- What is the size and penetration level of the Japanese generic market?
- How is the Japanese generic market different from other developed markets?
- What are the key drivers and challenges for the generic market?
- What is the role of government in the market?
- What is the viewpoint of patients and physicians on generic drugs?
- What is the future outlook of the drug market?
- Who are the key players operating in the Japanese generic market?
Key players operating in Japanese generic market
This report features the key players currently operating in the Japanese
pharmaceutical and generic markets. This section describes market shares and
growth of key pharmaceutical and generic players in Japan. Profiles of the
top six generic manufacturers have been provided in the report.
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
We are running a special offer on select reports, where you can avail our reports at discounted prices. Please click here to know more: http://www.rncos.com/promotion.htm
For more information visit: http://www.rncos.com/Report/IM170.htm
Current Industry News: http://www.rncos.com/Blog/
Published at Investorideas.com Financial Article Feed : http://www.investorideas.com/RSS/feeds/II-Art.xml
About InvestorIdeas.com: One of the first online investor resources providing in-depth information on renewable energy, greentech and water sectors.
Become an Investorideas.com Member
Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles, renewable energy and water stocks directory.
Learn more: http://www.investorideas.com/membership
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com®, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com® endorsing the content as a recommendation to buy or sell stock.
|
